Umbilical cord blood stem cells
Executive Summary
Efficacy data for use of stem cells from umbilical cord blood will be discussed by FDA's Biological Response Modifiers Advisory Committee Feb. 27. Committee will also hear updates on research programs in the Division of Monoclonal Antibodies. Meeting begins at 8 a.m. at the Holiday Inn in Silver Spring, Md...